Zydus Lifesciences revenue and financials

ZYDUSLIFE · NSE · INR

Compare Zydus Lifesciences
₹1,200.00Change from previous close: −0.24%Absolute change: −₹2.90

Close · November 20, 2026

In the fiscal year ended March 2026, Zydus Lifesciences reported revenue of ₹271.48B (+16.81% year over year). Net income was ₹50.4B, a net margin of 18.6%.

Annual revenue · 2026: ₹271.48B
  1. ₹93.77B2017
  2. ₹119.05B2018
  3. ₹131.66B2019
  4. ₹142.53B2020
  5. ₹144.04B2021
  6. ₹151.1B2022
  7. ₹172.37B2023
  8. ₹195.47B2024
  9. ₹232.42B2025
  10. ₹271.48B2026

Fiscal year ending in March. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+16.81%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+11.37%
FY to Mar 2026 vs FY to Mar 2025
Net margin
18.6%
FY to Mar 2025: 19.5%

How Zydus Lifesciences is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of INR; per-share values in INR; shares in millions.

Income statement · Annual
ItemFY to Mar 2026FY to Mar 2025FY to Mar 2024FY to Mar 2023FY to Mar 2022FY to Mar 2021FY to Mar 2020FY to Mar 2019FY to Mar 2018FY to Mar 2017
Total revenue271,484232,415195,474172,374151,099144,035142,531131,656119,04993,765
Cost of revenue75,23665,38463,93764,70756,85749,43450,80448,57442,44835,081
Gross profit196,248167,031131,537107,66794,24294,60191,72783,08276,60158,684
Selling, general and administrative64,83150,00742,45737,64932,49831,25033,08028,31524,87420,774
Research and development5,8795,3321,5581,358——————
Operating income58,24959,60245,39228,52824,74127,35621,01823,92623,24415,319
EBIT58,24959,60245,39228,52824,74127,35621,01823,92623,24415,319
EBITDA71,64668,30352,57235,34431,69534,15227,60229,74428,42318,989
Interest expense3,6509354401,2551,1441,5593,2361,9051,047568
Pre-tax income67,18260,84549,27326,84328,84324,46615,24224,29023,93616,484
Income tax15,94714,1199,7755,8785,1171,9363,1985,3035,6441,289
Net income50,40045,25538,59519,60344,87321,33611,76618,48817,75814,877
Net income to common shareholders50,40045,25538,36519,64922,41622,01611,76618,48817,94614,904
Basic EPS50.0944.9737.9119.3521.9021.5111.4918.0617.5314.56
Diluted EPS50.0944.9737.9119.3521.9021.5111.4918.0617.5314.56
Average shares (basic)1,0061,0061,0121,0161,0241,0241,0241,0241,0241,024
Average shares (diluted)1,0061,0061,0121,0161,0241,0241,0241,0241,0241,024
Dividend per share1.0011.003.006.002.503.503.503.503.503.20

Companies in the group: same industry, similar size